Intra-Cellular: 3Q Earnings Snapshot

November 7, 2018

NEW YORK (AP) _ Intra-Cellular Therapies Inc. (ITCI) on Wednesday reported a loss of $41.5 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 76 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 85 cents per share.

Intra-Cellular shares have climbed 17 percent since the beginning of the year. The stock has increased 15 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ITCI at https://www.zacks.com/ap/ITCI

Update hourly